Physician profile
Catherine Calvert
NPI 1467847723
$3,174.14
in general payments reported to CMS, 2019-2025
17 companies · $794 in 2025
The $794 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $467 · 2023: $905 · 2024: $1,008 · 2025: $794.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,827 · Education: $881.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,826.54 |
| Education | $880.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $880.97 | 2023-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Memorygel Breast Implant, Actis |
| Abbvie INC. | $460.61 | 2023-2024 | Alloderm |
| Integra Lifesciences Corporation | $379.21 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Polynovo North America LLC | $202.82 | 2024-2025 | Novosorb Btm |
| Allergan, INC. | $149.90 | 2022 | |
| Innovation Technologies INC | $149.02 | 2025 | Irrisept |
| Alafair Biosciences, INC. | $139.03 | 2022 | |
| Depuy Synthes Sales INC. | $138.41 | 2023 | Na, Rapidsorb |
| Tela Bio, INC. | $122.81 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Davol INC. | $121.11 | 2022 | |
| Avita Medical Americas, LLC | $115.61 | 2024 | |
| Solventum Corporation | $106.11 | 2025 | V.A.C. Veraflo |
| Kerecis Limited | $67.73 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Kls-Martin L.P. | $66.13 | 2024 | |
| Djo, LLC | $40.68 | 2024 | Cmf |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Crossroads Orthopedics, LLC | $17.94 | 2024 | |
| Olympus America INC. | $16.05 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Calvert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.